MIDA is a new method for measuring, with stable isotope labelled precursors, the biosynthesis of compounds synthesized from the addition of several identical or comparable precursor molecules, such as glucose from two triosephosphates. It does this by allowing the calculation of the enrichment of the precursor pool.
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In vitro, this method is valid. We have used it in vivo to quantify the total GNG in control rats (n = 6) and in rats with streptozocin-induced diabetes (n = 6). All rats were studied in the postabsorptive state. We used [3-3 H] glucose for measuring the hepatic glucose production (HGP) and [2-13 C] glycerol as a gluconeogenic tracer. Using GC-MS, the total !3C glucose enrichment (IE) and glucose isotopomer distribution were measured to calculate the contribution of GNG to HGP.
In diabetic rats, glycaemia and HGP levels were higher than in control (26.4 ± 0.8 vs 8.6±0.2mM, P 0.05 and 109±6vs67± ± 3 pmol/kg/min, P < 0.05). The contribution of GNG to HGP was increased (67 ± 3 vs 53 ± 4%, P < 0.05) and the absolute GNG level was twice as high (73 ± 5 vs 37 ± 4 umol/kg/min, P < 0.05) while nongluconeogenic glucose production remained unchanged (36 ± 3 vs 31 ± 2 pmol/kg/min, P < 0.05).
We 11.2 ±0.8 to 9.8 ±0.7, P < 0.01). The response was heterogeneous, six 'responders' showed an absolute hyperglycemic response (10.8 ± 1.0 to 11.8 ± 0.8), while nine 'nonresponders' did not, in a similar manner to the saline controls (11.4 ± 1.2 to 10.5 ± 1. 
